Price quotes for Sibutramine from multiple providers

OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) provided an informational
update on data from its two preclinical development compounds, PSN821
and PSN602. This information was presented at the annual meeting of
the American Diabetes Association in San Francisco, CA. Preclinical
data on PSN821, a novel, orally available agonist of the G-protein
coupled receptor GPR119, bei…